Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1678797

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1678797

Japan Telemedicine Market - 2025-2033

PUBLISHED:
PAGES: 140 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3175
PDF & Excel (Multiple User License)
USD 3500
PDF & Excel (Enterprise License)
USD 6850

Add to Cart

The Japan Telemedicine market reached US$ 5,142.91 million in 2024 and is expected to reach US$ 25,867.49 million by 2033, growing at a CAGR of 19.5% during the forecast period 2025-2033.

Telemedicine is a remote healthcare delivery method that uses telecommunications technology to provide medical advice, diagnoses, and treatment plans to patients. It addresses barriers to healthcare access like geographical distance, time constraints, and patient mobility issues. Telemedicine is particularly beneficial in rural areas with healthcare workforce shortages. As technology advances, telemedicine incorporates tools like remote monitoring, AI-driven diagnostics, and mobile health Speciality Areas, making it a key part of the digital healthcare revolution.

Market Dynamics: Drivers & Restraints

Aging Population and Rising Remote Healthcare Demand in Japan

The Japan telemedicine market is driven by the aging population and increasing demand for remote healthcare. With a significant percentage of the population aged 65 and above, Japan is facing a high incidence of chronic conditions like diabetes, hypertension, and cardiovascular diseases. Telemedicine offers a convenient solution, especially for elderly individuals in remote areas. Remote consultations and monitoring systems bridge the gap between patients and healthcare providers, ensuring timely care and reducing hospital visits. This increased reliance on telemedicine is driving market growth in Japan.

For instance, Japan's inpatient care demand is expected to peak by 2040, leading to medical and welfare workers becoming the largest industry by 2035-2040. Healthcare expenditures in 2040 are projected to reach ¥89 trillion, 1.6 times higher than in 2023, causing a ¥27 trillion financial shortfall. To maintain current medical care levels, the government may need to reduce low-value care, shift tasks from physicians to other professions, and improve efficiency through digital transformation.

Regulatory Challenges and Data Privacy Concerns

The Japan telemedicine market faces regulatory challenges and data privacy concerns due to strict healthcare regulations. While telemedicine can improve healthcare access, these regulations limit the widespread adoption of digital health solutions. Telemedicine platforms must comply with patient confidentiality, data security, and licensing requirements. Ensuring secure transmission and storage of personal health data is a major concern, especially amid rising cybersecurity threats. This complex regulatory landscape could slow telemedicine service growth in Japan.

Segment Analysis

The Japan telemedicine market is segmented based on type, specialty area, and end user

Type:

mHealth in the type segment is expected to dominate with the highest market share

Mobile health (mHealth) is a key in Japan's telemedicine landscape, enhancing accessibility, efficiency, and patient engagement. It enables remote monitoring, virtual consultations, and chronic disease management through smartphones and wearable devices. It supports the aging population by enabling real-time health tracking and medication adherence. mHealth integrates with EHRs and AI for improved diagnostic accuracy and personalized treatment plans. Government initiatives and regulatory support drive its expansion.

End User:-

Hospitals are expected to dominate the end-user segment with the highest market share.

The hospital segment is the fastest-growing segment in the telemedicine market share and is expected to hold the market share over the forecast period.

Japan's hospitals are integrating digital health solutions into their services, particularly in rural areas with limited resources. They are using telemedicine platforms to provide remote consultations, specialist access, and follow-up care to patients who cannot visit in person. This reduces wait times and alleviates pressure on staff and infrastructure. Telemedicine is also being used to improve patient monitoring for chronic conditions. As Japan's healthcare system transitions towards patient-centered care, telemedicine is being increasingly adopted to enhance efficiency, reduce readmissions, and improve patient outcomes.

Competitive Landscape

The major country players in the Telemedicine market include Nihon Kohden Corporation, MEDLEY, INC, Terumo Corporation, M3, Inc, Medmain, PK Telehealth, NTT Data Inc, Sony Corporation, and others.

Key Developments

  • In April 2024, Japan's internal affairs ministry launched an initiative to offer online doctor consultations and medication guidance through private booths at post offices, with drugs delivered via postal service.
  • In June 2024, Infosys partnered with Japan's dispensing pharmacy chain, Nihon Chouzai, to improve healthcare access in Japan. The partnership includes the development of a mobile application, NiCOMS, which offers remote medication guidance from registered pharmacists, eliminating the need for pharmacy visits.

Why Purchase the Report?

  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth countries and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.

The Japan Telemedicine market report delivers a detailed analysis with 33 key tables, more than 27 visually impactful figures, and 140 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Speciality Area & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.
Product Code: HCIT9292

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Specialty Area
  • 3.3. Snippet by End User

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Aging Population and Rising Remote Healthcare Demand in Japan
    • 4.1.2. Restraints
      • 4.1.2.1. Regulatory Challenges and Data Privacy Concerns
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 6.1.2. Market Attractiveness Index, By Type
  • 6.2. mHealth*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Tele Hospitals/Clinics
  • 6.4. Telehome

7. By Specialty Area

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specialty Area
    • 7.1.2. Market Attractiveness Index, By Specialty Area
  • 7.2. Dermatology*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cardiology
  • 7.4. Gynecology
  • 7.5. Psychiatry
  • 7.6. Trauma Care
  • 7.7. Others

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Clinics
  • 8.4. Others

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

Key Market Players

  • 10.1. Nihon Kohden Corporation*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue's
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. MEDLEY, INC
  • 10.3. Terumo Corporation
  • 10.4. M3, Inc
  • 10.5. Medmain
  • 10.6. PK Telehealth
  • 10.7. NTT Data Inc
  • 10.8. Sony Corporation
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

11. Appendix

  • 11.1 About Us and Services
  • 11.2 Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!